| Title | Monosomal karyotype is associated with poor outcomes in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia receiving chemotherapy but not allogeneic hematopoietic stem cell transplantation |
| Authors | Li, Zongru Lai, Yueyun Zhang, Xiaohui Xu, Lanping Liu, Kaiyan Wang, Yu Yan, Chenhua Jiang, Hao Huang, Xiaojun Jiang, Qian |
| Affiliation | Peking Univ, Peoples Hosp, Inst Hematol, Natl Clin Res Ctr Hematol Dis,Beijing Key Lab Hem, Beijing, Peoples R China |
| Keywords | ACUTE MYELOID-LEUKEMIA HYPER-CVAD COMPLEX KARYOTYPE REGIMEN ADULTS CYTOGENETICS PROGNOSIS SURVIVAL IMPACT |
| Issue Date | Jun-2020 |
| Publisher | ANNALS OF HEMATOLOGY |
| Abstract | Monosomal karyotype (MK) is associated with poor prognosis in patients with myeloid neoplasms; however, its prognostic significance in Philadelphia chromosome-negative (Ph-negative) acute lymphoblastic leukemia (ALL) remains unclear. Data of 323 patients with Ph-negative ALL treated at Peking University People's Hospital were retrospectively analyzed. MK was identified in 49 (14.8%) patients. The patients with MK had lower hemoglobin levels (P = 0.026), lower platelet count (P = 0.032), higher percentages of blasts in the peripheral blood at diagnosis (P = 0.008), and higher percentages of high-risk karyotypes (P < 0.001) compared with those without MK. The complete remission (CR) rate and the minimal residual disease negativity rate were not significantly different between patients with and without MK. In the multivariate analysis, MK was identified as an independent factor associated with higher cumulative incidence of relapse (CIR) (hazard ratio (HR), 2.07; 95% confidence interval (CI), 1.02, 4.21;P = 0.043), shorter disease-free survival (DFS) (HR, 2.80; 95% CI, 1.20, 6.54;P = 0.017) and shorter overall survival (OS) (HR, 5.75; 95% CI, 2.07, 16.03;P = 0.001) in the chemotherapy cohort; however, MK had no impact on outcomes in the allogeneic hematopoietic stem cell transplantation (allo-HSCT) cohort. Mantel-Byar analysis showed that allo-HSCT was associated with lower CIR (P < 0.001), longer DFS (P < 0.001), and longer OS (P < 0.001) in CR patients with MK. In conclusion, our study showed that MK was an independent predictor of poor outcomes in patients with Ph-negative ALL receiving chemotherapy but not allo-HSCT, and allo-HSCT could improve the outcomes of patients with MK. |
| URI | http://hdl.handle.net/20.500.11897/607126 |
| ISSN | 0939-5555 |
| DOI | 10.1007/s00277-020-04155-7 |
| Indexed | SCI(E) |
| Appears in Collections: | 人民医院 |
